Oak Associates’s Telix Pharmaceuticals TLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$134K Buy
+12,244
New +$139K 0.01% 144

Other funds holding TLX

Oak Associates's TLX Position: Q3 2026 in Review

Oak Associates opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 12,244 shares worth $134K. The stake represents 0.01% of the portfolio and ranks #144 among its holdings.

74 funds tracked by Wall St. Rank hold TLX as of Q3 2026.

  • Oak Associates held 12,244 shares of Telix Pharmaceuticals worth $134K as of Q3 2026.
  • Telix Pharmaceuticals was a new Oak Associates position in Q3 2026.
  • Telix Pharmaceuticals made up 0.01% of Oak Associates's portfolio in Q3 2026, its #144 holding.
  • 74 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.

Based on Oak Associates's 13F filing for Q3 2026, filed 16 Nov 2026.